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1. Introduction  
In Japan, 27 hospitals specialize in treatment of muscular dystrophy patients, including 
inpatient care, of which 26 belong to the National Hospital Organization, and the other is 
the National Center of Neurology and Psychiatry. Since 1999, Japanese muscular dystrophy 
research groups investigating nervous and mental disorder have been developing a 
database of cases treated at these 27 institutions. In that regard, we conducted a survey of 
inpatients and home-mechanical ventilation patients (HMV patients) with muscular 
dystrophy and other neuromuscular disorders based on data collected by the National 
Hospital Organization and National Center of Neurology and Psychiatry.  
Herein, we examined data obtained in order to evaluate efficacy of mechanical ventilation 
therapy for HMV patients and mechanical ventilation-dependent inpatients (MV inpatients) 
with those wards.  
2. Subjects and methods 
The database includes numbers of inpatients, gender, age, diagnosis, respiratory condition, 
nutritional state, number of death cases, causes of death, and other relevant findings from 
data collected annually on October 1 every year since 1999. Additionally we collected the 
data of HMV patients from 27 institutes for this study.  
By using the database and newly collected HMV data, we analyzed the courses of HMV 
patients group and those of MV inpatients of wards. We compared data of these two 
groups. Examination points are mechanical ventilation periods, outcome of these two 
groups, and caregiver for HMV patients.  
2.1 Objective diseases  
Objective diseases of this study were muscular dystrophy and spinal muscular atrophy, in 
particular Duchenne muscular dystrophy and myotonic dystrophy. Amyotrophic lateral 
sclerosis was not included. 
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2.2 Patients introduced HMV after 1999 
The data which we requested 27 institutes specializing muscular dystrophy care was as 
follows; the number of patients introduced HMV after 1999, diagnosis of disease, gender, 
age at being introduced HMV, type of mechanical ventilation, such as non-invasive positive 
pressure ventilation (NPPV) or tracheostomy intermittent ventilation (TIV), present status, 
death cause for death case, main caregiver, and so on. 
2.3 Patients introduced MV in muscular dystrophy wards after 1999 
We selected data of newly MV introduced inpatients after 1999 from the database of the 
muscular dystrophy wards. 
3. Results  
3.1 Demographic features of HMV patients group and MV inpatients 
3.1.1 HMV patients group 
HMV patients group included 434 patients from 14 institutes. Gender was male: 356, female: 
78. The number of representative disease were as follows; 262 patients with Duchenne 
muscular dystrophy, 60 myotonic dystrophy, 17 Becker muscular dystrophy, 16 limb-girdle 
muscular dystrophy, 14 spinal muscular atrophy, and so on (Table 1-1).  
 
BMD, Becker muscular dystrophy; CMD, congenital muscular dystrophy; DMD, Duchenne muscular 
dystrophy; EDMD, Emery-Dreifuss muscular dystrophy; FCMD, Fukuyama congenital muscular 
dystrophy; FSHD, facio-scapulo-humeral muscular dystrophy; LGMD, limb-girdle muscular dystrophy; 
MD, Myotonic dystrophy; MG, myasthenia gravis; SMA, spinal muscular atrophy; SPMA, spinal 
progressive muscular atrophy, UCMD, Ullrich congenital muscular dystrophy 
Table 1-1. Details of disease（HMV: from 14 institutes） 
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3.1.2 MV inpatients group 
MV inpatients group included 915 inpatients. Gender was male: 718, female: 197. The 
number of representative disease were as follows; 476 Duchenne muscular dystrophy, 222 
myotonic dystrophy, 35 Becker muscular dystrophy, 58 limb-girdle muscular dystrophy, 19 
spinal muscular atrophy, and so on (Table 1-1). 
3.1.3 Mean age at starting mechanical ventilation and type of ventilation 
The range of mechanical ventilation introduction age for HMV patients was 6.3~72.8 years 
old (mean 25.9), and that of MV inpatients was 0.0~78.0 years old (mean 33.2). The number 
of NPPV introduction cases of HMV patients was 420, and that of MV inpatients was 517 
(Table 1-2). Fifty of NPPV cases of HMV group were switched to tracheostomy during the 
course. 
 
Table 1-2. Mean age at starting mechanical ventilation and type of ventilation 
3.2 Survival analysis of HMV patients group and MV inpatients 
We performed survival analysis of those two groups. The endpoint for HMV patients was 
death or transition to hospitalization, and that for MV inpatient was death. Kaplan-Meier 
analysis showed that 75% life time of HMV patients was 1,689 days, while that of inpatients 
was 2,988 days (Log Rank (Mantel-Cox) p<0.01) (Fig. 1). 
 
Fig. 1. Comparison between HMV Patients and Mechanical Ventilation Inpatients (Total) 
Endpoint for HMV patient: death or transition to hospitalization  
Endpoint for MV inpatient: death 
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3.3 Analysis data of Duchenne muscular dystrophy and myotonic dystrophy 
As the number of patients with Duchenne muscular dystrophy and myotonic dystrophy 
was great in these two groups, we analyzed the data of Duchenne muscular dystrophy and 
myotonic dystrophy separately.  
3.3.1 Mean age at starting mechanical ventilation and type of ventilation of patients 
with Duchenne muscular dystrophy 
Mean age at starting mechanical ventilation of Duchenne muscular dystrophy was 19.8 
years old, ranged from 11.5 to 39.9 years old. While that of inpatient with Duchenne 
muscular dystrophy was 21.5 years old, ranged from 10.0 to 42.0 years old. There was no 
significant difference. The number of NPPV introduction cases of HMV patients with 
Duchenne muscular dystrophy was 220, and that of MV inpatients was 338 (Table 2). 
 
Table 2. Mean age at starting mechanical ventilation and type of mechanical ventilation  
(Duchenne muscular dystrophy ) 
3.3.2 Type of nutrition of patients with Duchenne muscular dystrophy 
The number of patients who required tube feeding, including a nasal or oral nutrition tube, 
and undergoing a percutaneous endoscopic gastrostomy (PEG) was apparently greater in 
MV inpatients group than HMV group (Table 3).  
 
Table 3. Type of nutrition  (Duchenne muscular dystrophy ) 
3.3.3 Survival analysis of two Duchenne muscular dystrophy groups 
We performed survival analysis of those two Duchenne muscular dystrophy groups. The 
endpoint for HMV patients was death or transition to hospitalization, and that for MV 
inpatient was death. Kaplan-Meier analysis showed that 75% life time of HMV patients 
was 1,562 days, while that of inpatients was 3,739 days (Log Rank (Mantel-Cox) p<0.01) 
(Fig. 2). 
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Fig. 2. Comparison between HMV Patients and Mechanical Ventilation Inpatients 
(Duchenne muscular dystrophy ) 
Endpoint for HMVpatient: death or transition to hospitalization  
Endpoint for MV inpatient: death 
3.3.4 Mean age at starting mechanical ventilation and type of ventilation of patients 
with myotonic dystrophy 
Mean age at starting mechanical ventilation of myotonic dystrophy was 46.8 years old, 
ranged from 15.8 to 72.8 years old. While that of inpatient with myotonic dystrophy was 
50.6 years old, ranged from 12.0 to 76.0 years old. There was no significant difference 
between two groups. The number of NPPV introduction cases of HMV patients with 
myotonic dystrophy was 55, and that of TIV was 5. The number of NPPV case was greater 
than TIV. While the number of NPPV introduction cases of MV patients with myotonic 
dystrophy was 108, and that of TIV was 114. In MV patients with myotonic dystrophy, the 
number and proportion of NPPV and TIV were almost equal (Table 4). 
 
Table 4. Mean age at starting mechanical ventilation and type of mechanical ventilation  
(myotonic dystrophy ) 
3.3.5 Type of nutrition of patients with myotonic dystrophy 
The trend of nutrition was similar to Duchenne muscular dystrophy. The number who 
required tube feeding in MV inpatients group was apparently greater than HMV group 
(Table 5).  
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Table 5. Type of nutrition (myotonic dystrophy ) 
 
Fig. 3. Comparison between HMV Patients and Mechanical Ventilation Inpatients 
(myotonic dystrophy )  
Endpoint for HMVpatient: death or transition to hospitalization  
Endpoint for MV inpatient: death 
3.3.6 Survival analysis of two myotonic dystrophy groups 
Similarly, we performed survival analysis of those two myotonic dystrophy groups. The 
endpoint for HMV patients was death or transition to hospitalization, and that for MV 
inpatient was death. Kaplan-Meier analysis showed that 75% life time of HMV patients was 
1,557 days, while that of inpatients was 1,972 days. There was no significance (Fig. 3).   
3.4 Death case 
The total number of death cases was 215 (Table 1-1). As the number of death case of 
Duchenne muscular dystrophy and myotonic dystrophy was the majority, we analyzed the 
data of Duchenne muscular dystrophy and myotonic dystrophy separately. 
3.4.1 Cause of death of Duchenne muscular dystrophy 
The number of death cases of HMV patients was 29, and that of MV inpatients was 67. 
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The most frequent cause of death was heart related disorders, such as heart failure and 
arrhythmia, accounting for 16/29 for HMV group and 33/67 for MV inpatient group. 
Frequency was not significantly different between two groups. In MV inpatient group, 
respiratory related disorders, such as respiratory failure and respiratory infection, 
accounted for 23/67．HMV group included more sudden death cases than MV inpatient, 
and had an accidental case (Table 6).  
 
Table 6. Cause of death (Duchenne muscular dystrophy ) 
3.4.2 Cause of death of myotonic dystrophy 
The majority of death case of myotonic dystrophy was reported from MV inpatient group. 
The most frequent cause was respiratory related disorders, such as respiratory tract 
infection and respiratory failure, which accounted for 29/56. Sudden death case was 
conspicuous in HMV group, accounting for 3/6(Table 7). 
 
Table 7. Cause of death (myotonic dystrophy ) 
 
Neuromuscular Disorders 
 
112 
3.5 Outcome of HMV patients and MV inpatients with Duchenne muscular dystrophy 
and myotonic dystrophy 
One hundred ninty four cases with Duchenne muscular dystrophy among 262 cases continued 
HMV, while 46 cases with myotonic dystrophy among 60 cases continued HMV (Table 8). 
Twenty two cases with Duchenne muscular dystrophy were switched to hospitalization. 
HMV Inpatient HMV Inpatient
Continuing HMV 194 - 46 -
Continuing hospitalization - 407 - 151
Death 29 67 6 56
Transition to hospitalization 22 - 3 -
Introduction to other 
institution
10 - - -
Withdrawing MV - - 3 -
Unknown 7 2 - -
 Others - - 2 15
total 262 476 60 222
DMD MD
 
Table 8. Outcome (Duchenne muscular dystrophy and myotonic dystrophy ) 
3.6 Caregivers for HMV patients  
Caregivers for most of HMV patients with Duchenne muscular dystrophy were patients' 
families (Table 9). In particular, patients’ mothers were playing important role in continuing 
HMV. Similarly, caregivers for HMV patients with myotonic dystrophy were patients' 
families. On reflecting their age, some caregivers were patient’ spouse (Table 9). 
Caregiver DMD MD
Mother 94 6
Parents 22
Father 3 2
Family 3
Mother/sibling 1
Mother/uncle 1
Mother/grandmother 1
Grandmother 1
Husband 2
Wife 1
Sister 1
daughter 1
foundation 2
Helper 2 2
(Response)  (134/262) (17/60)  
Table 9. HMV-continuing cases main caregiver (Duchenne muscular dystrophy and 
myotonic dystrophy)  
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3.7 Summary of results of Duchenne muscular dystrophy and myotonic dystrophy 
Proportion of TIV was higher in MV inpatients group than HMV group. And proportion of 
tube feeding was also higher in MV inpatients group than HMV group. Namely, respiratory 
condition and nutritional status were more severe in MV inpatients group than HMV group 
(both Duchenne muscular dystrophy and myotonic dystrophy). 
In Survival analysis, outcome of patients with Duchenne muscular dystrophy of MV 
inpatients group was better than HMV group. Meanwhile in that of myotonic dystrophy, 
HMV group was better than inpatient group. 
In MV inpatient group of Duchenne muscular dystrophy, respiratory related death was 
remarkable. 
In HMV group, some sudden death cases and accidental death case were conspicuous. 
Caregivers of HMV group were constructed by patients’ families, centrally mother. 
4. Conclusion 
Approximate 2500 beds for patients with muscular dystrophy and related disorders are now 
provided among 27 institutions in Japan. In accordance with progress in therapeutic 
strategies for respiratory failure (American Thoracic Society Documents, 2004) and heart 
failure (Ishikawa, 1999; Matsumura, 2010), the life span of patients with muscular dystrophy 
prolonged (Bushby 2010a, b). Now, most inpatients admitted to muscular dystrophy wards 
have severe general conditions and many are assisted by mechanical ventilation (Tatara, 
2006; 2008), which is accordance with our data of MV patients in this study. 
In recent two decades, social welfare systems and home medical care systems in Japan have 
been changing gradually. HMV has been penetrating into home medical care (Joseph, 2007). 
The number of HMV patients has been increasing (Tatara, 2006). Stable mechanical 
ventilated patients have been getting back home. 
Our study demonstrated that the course of HMV patients was fairly good, although there 
was difference between Duchenne muscular dystrophy and myotonic dystrophy in long 
term outcome. However, the support system for patients and caregivers is not perfect. Our 
study also showed that burden of caregivers was supposed to be severe. The system for 
patients and caregivers should be adjusted (Dybwik, 2011). And safety net systems also 
should be adjusted to avoid accidental event leading to patient’s death. 
The muscular dystrophy wards may be requested to offer the circumstances for those who 
have difficulties in continuing HMV. There is necessarily needs for hospitalization of HMV 
patients (Windisch, 2008).  
Study limitation: This study has limitation on bias of collecting patients’ information. 
Specifically, information of HMV patients were reported from 14 institutes among 27 
institutes, and MV inpatient information is the result of extraction from muscular dystrophy 
wards database. Extracted data from database has some ambiguous points in connection 
with obscure time-sequential analysis. 
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On analysis of institutes-restricted HMV patients group and MV inpatients group, 
differences in regard to therapeutic conditions among institutions may be problem. 
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Institutions specializing in muscular dystrophy treatment in Japan (Fig.4) 
 
 
 
 
Fig. 4. Institutions specializing in muscular dystrophy treatment in Japan  
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National Hospital Organization: 
Asahikawa Medical Center, Yakumo Hospital, Aomori National Hospital, 
Akita National Hospital, Nishitaga National Hospital, East Saitama National Hospital, 
Shimoshizu National Hospital, National Hakone Hospital, Niigata National Hospital,  
Iou National Hospital, Nagara Medical Center, Suzuka National Hospital,  
Nara Medical Center, Utano Hospital, Toneyama National Hospital,  
Hyogo-cyuo National Hospital, Hiroshima-Nishi Medical Center, Matsue Medical Center, 
Tokushima National Hospital, Oomuta Hospital, Nagasaki Kawatana Medical Center,  
Kumamoto Saishunso National Hospital, Nishibeppu National Hospital,  
Miyazaki Higashi Hospital, Minami Kyushu National Hospital, Okinawa National Hospital  
National Center of Neurology and Psychiatry  
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